Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Integrated Mesh-Fascial Closure for Incisional Hernia Repair

Official title: Prospective Comparative Evaluation of the Integrated Mesh-Fascial Closure (IMFC) Technique Versus Standard Closure of the Abdominal Wall: A Quasi-Experimental, Non-Randomized Study

Run by Hospital Zonal General De Agudos Mario V Larrain · NCT07843225 · Data updated 2026-11-12

This study tests whether incorporating a mesh into the fascial closure during incisional hernia repair helps reduce recurrences compared with standard closure, in adults who need mesh placement.

More Incisional Hernia trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorHospital Zonal General De Agudos Mario V Larrain
Academic / other
Locations1 site (Berisso, Buenos Aires)
StatusRecruiting
StartedSeptember 28, 2026
Main results expectedOctober 15, 2030
Study endsOctober 15, 2032
Registry record updatedOctober 14, 2026
Trial IDNCT07843225 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 undergoing laparotomy with an indication for prophylactic mesh placement or undergoing repair for incisional/ventral hernia, including recurrent hernias and defects >4 cm.

Probably not a fit

Patients with active infection, contamination, non-viable tissue, loss of domain, or other exclusion criteria may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, non-randomized study compares two abdominal wall closure techniques in adults with incisional or ventral hernias and planned mesh use. One group uses the standard fascial closure with mesh fixed separately, while the other uses Integrated Mesh-Fascial Closure (IMFC), weaving a macroporous mesh into the fascial suture. Participants choose their group after informed consent and are followed for 18 to 24 months with clinical assessments and imaging to assess safety, feasibility, and recurrence. The study is conducted at a single center in Argentina and aims to standardize IMFC and compare outcomes to standard closure. Background data indicate incisional hernia is common and recurrence after mesh repair can be substantial, motivating this comparative evaluation.

Why it matters

Potential benefit: If successful, IMFC could lower hernia recurrence and improve long-term durability of repair.

How similar studies have gone: Prior description of the IMFC concept exists, with a non-randomized, prospective approach showing potential feasibility, but this study adds prospective comparison.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults older than 18 years of age
* Patients with incisional (ventral) hernia
* Patients with recurrent incisional hernia
* Incisional hernias with a diameter greater than 4 cm
* Patients undergoing laparotomy with an indication for prophylactic mesh placement

Exclusion Criteria:

* Active surgical site infection
* Overt abdominal contamination
* Tissue necrosis or inability to achieve primary fascial closure
* Non-correctable loss of domain
* Pregnant women or women of childbearing potential planning pregnancy or not using contraception during the follow-up period
* Patients belonging to vulnerable populations, in accordance with Law 15.462 and applicable ethical guidelines
* Active oncologic disease (patients with a cured oncologic history may be included)

Where it's running

  • Hospital Zonal General de Agudos "Dr. Mario V. Larrain
    Berisso, Buenos Aires, Argentina
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.